25 completed. 25 Phase 1, 8 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 25 | Completed 25 |
| Phase 2 | 8 | Completed 8 |
Follow Communication Disorders: new trials by email Literature Review of Communication Disorders trials Research Report on Communication Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Wellbeing After Stroke (WAterS): Supporting Adjustment and Wellbeing After Stroke Acceptance and Commitment Therapy - Stroke, Psychological Distress | Phase 1 | Completed | University of Manchester | 20 | 2021-01-05 | 2024-05-10 |
| Comparing Traditional and Biofeedback Telepractice Treatment for Residual Speech Errors Visual-acoustic biofeedback, Motor-based treatment - Speech Sound Disorder | Phase 1 | Completed | New York University | 7 | 2020-09-01 | 2023-02-13 |
| Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S QBS10072S - Astrocytoma, Brain Cancer | Phase 1 | Completed | Quadriga Biosciences, Inc. | 15 | 2020-07-20 | 2023-01-18 |
| Proof-of-concept Study of LUNA Intervention in Aphasia LUNA - Aphasia, Stroke | Phase 1 | Completed | City, University of London | 28 | 2020-06-14 | 2023-05-06 |
| Intranasal Inhalations of M2 Macrophage Soluble Factors in Children With Developmental Speech Disorders Bioactive Factors, Produced by M2 Type Macrophages (M2-BFs). - Language Delay, Language; Developmental Disorder, Expressive | Phase 1 / Phase 2 | Completed | Russian Academy of Medical Sciences | 14 | 2020-02-01 | 2022-05-02 |
| Delineation of Sensorimotor Subtypes Underlying Residual Speech Errors Visual-acoustic biofeedback, Ultrasound biofeedback - Speech Sound Disorder | Phase 1 | Completed | New York University | 7 | 2019-03-01 | 2023-12-11 |
| Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia and Frontotemporal Dementia F-18 AV 1451 - Primary Progressive Aphasia, Behavioral Variant of Frontotemporal Dementia | Phase 1 | Completed | Mayo Clinic | 81 | 2016-07-01 | 2025-11-21 |
| Brief Behavioral Treatment for Anxiety in Young Children Parent-Led Exposure Therapy, Treatment As Usual - Obsessive-compulsive Disorder, Social Phobia | Phase 1 / Phase 2 | Completed | University of South Florida | 58 | 2014-01-01 | 2016-10-06 |
| Ultrasound Biofeedback for Speech Sound Disorders Ultrasound visual feedback - Speech Sound Disorders | Phase 1 | Completed | Yale University | 35 | 2013-05-01 | 2020-04-03 |
| Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD C-11 PiB - Atypical Alzheimers Disease, Logopenic Variant of Primary Progressive Aphasia (LPA) | Phase 1 | Completed | Mayo Clinic | 27 | 2012-11-01 | 2015-12-21 |
| Effects of tDCS Versus HD-tDCS for Stroke Rehabilitation HD-tDCS (Soterix), Transcranial Direct Current Stimulation (Neuroconn) - Chronic Aphasia | Phase 1 | Completed | Soterix Medical | 2012-03-01 | 2015-08-26 | |
| Building Complex Language Complex sentence treatment protocol - Language Development Disorders, Learning Disorders | Phase 1 / Phase 2 | Completed | Governors State University | 31 | 2011-04-01 | 2013-11-25 |
| Animal Assisted Therapy in a Pediatric Setting Animal Assisted Therapy - Developmental Delays, Global Developmental Delay | Phase 1 / Phase 2 | Completed | Children's Hospitals and Clinics of Minnesota | 30 | 2011-01-01 | 2014-02-14 |
| Mobility Training to Improve Motor Behavior in Toddlers With or at Risk for Cerebral Palsy: A Pilot Study mobility training with dynamic body weight support - Developmental Delay, Cerebral Palsy | Phase 1 | Completed | National Institutes of Health Clinical Center (CC) | 5 | 2010-11-15 | 2019-12-17 |
| Transcranial Direct Current Stimulation and Aphasia Language Therapy Transcranial Direct Current Stimulation - Cathodal stimulation, Transcranial Direct Current Stimulation - Anodal stimulation, Transcranial Direct Current Stimulation - Sham stimulation - Nonfluent Aphasia, Stroke | Phase 1 | Completed | Shirley Ryan AbilityLab | 12 | 2010-03-01 | 2017-05-15 |
| PiB PET Scanning in Speech and Language Based Dementias C-11 PiB, F-18 FDG - PPA, Primary Progressive Aphasia | Phase 1 | Completed | Mayo Clinic | 168 | 2010-03-01 | 2015-12-22 |
| Davunetide (AL-108) in Predicted Tauopathies - Pilot Study davunetide (AL-108, NAP), Placebo nasal spray - Predicted Tauopathies, Including, Progressive Supranuclear Palsy | Phase 1 | Completed | University of California, San Francisco | 12 | 2010-01-01 | 2019-04-05 |
| Outcomes In Children With Developmental Delay And Deafness cochlear implantation, hearing aids - Deafness, Hearing Loss | Phase 1 | Completed | Stanford University | 303 | 2009-09-01 | 2016-11-15 |
| My Scrivener® - Measuring Effectiveness and Dose Response in Children My Scrivener(R) - Asperger's Syndrome, Dyslexia | Phase 1 / Phase 2 | Completed | Obslap Research LLC | 176 | 2009-04-01 | 2010-10-28 |
| Implementation of Climb Up Program for Children With Attention Deficit Hyperactivity Disorder (ADHD) and Dyslexia in a School in India Climb Up ADHD and Dyslexia Program - Attention Deficit Hyperactivity Disorder, Dyslexia | Phase 1 / Phase 2 | Completed | Climb Up Kids | 76 | 2007-05-01 | 2015-08-04 |
Showing 20 of 25. Sign in to see all of them.
Stroke (9) · Aphasia (6) · Learning Disabilities (5) · Language (4) · Speech (4) · Aphasia, Broca (3) · Attention Deficit Disorder with Hyperactivity (3) · Speech Sound Disorder (3) · Aphasia, Primary Progressive (2) · Cerebral Palsy (2) · Dyslexia (2) · Frontotemporal Dementia (2) · Ischemic Stroke (2) · Language Development Disorders (2) · Neoplasms (2)
Nervous System Diseases (22) · Neurobehavioral Manifestations (22) · Neurologic Manifestations (22) · Pathological Conditions, Signs and Symptoms (22) · Signs and Symptoms (22) · Language Disorders (16) · Brain Diseases (15) · Central Nervous System Diseases (15) · Mental Disorders (15) · Neurodevelopmental Disorders (13) · Speech Disorders (11) · Cardiovascular Diseases (9) · Cerebrovascular Disorders (9) · Vascular Diseases (9)
2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole (2) · Transcranial Direct Current Stimulation (2) · Acceptance and Commitment Therapy (1) · Animal Assisted Therapy (1) · Cochlear Implantation (1) · Hearing Aids (1) · Therapeutics (1) · Transcranial Magnetic Stimulation (1) · davunetide (1)
Mayo Clinic (3) · New York University (2) · Boston University (1) · Children's Hospitals and Clinics of Minnesota (1) · City, University of London (1) · Climb Up Kids (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · Governors State University (1) · National Institutes of Health Clinical Center (CC) (1) · Northstar Neuroscience (1) · Obslap Research LLC (1) · Quadriga Biosciences, Inc. (1) · Rush University Medical Center (1) · Russian Academy of Medical Sciences (1) · Shirley Ryan AbilityLab (1)
United States (19) · United Kingdom (2) · Australia (1) · India (1) · Russia (1)
Adam L. Boxer, M.D., Ph.D. (1) · Alexander A Ostanin, MD, PhD (1) · Alvaro Pascual-Leone, M.D., Ph.D. (1) · Audrey Bowen, PhD (1) · Bruce Crosson, PhD (1) · Catherine H Balthazar, PhD (1) · Cheryl M Scott, PhD (1) · Connie Kasari, PhD (1) · Devendra Mehta, MBBS MSC MRCP (1) · Diane L Damiano, Ph.D. (1) · Elena R Chernykh, MD, PhD (1) · Emily Wang, PHD (1) · Emma Patchwood, PhD (1) · H B Coslett, M.D. (1) · Jennifer Whitwell, PhD (1)
PMID 15118944, PMID 15766771, PMID 16006338, PMID 19695692, PMID 20145986, PMID 20159655, PMID 20299861, PMID 21794852, PMID 21864891, PMID 23106988, PMID 23280015, PMID 26704258, PMID 29256908, PMID 34232693, PMID 35607935, PMID 38505946, PMID 38875279
R01DC017476 (2), R01DC005672 (1), R01DC007387 (1), R01DC010075 (1), R21DC009876 (1), R21NS094684 (1), R41NS076123 (1)